false
OasisLMS
Login
Catalog
PA-State Approved Medical Marijuana Course (On-Dem ...
On-Demand Live Recording
On-Demand Live Recording
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
This transcript is from a Pennsylvania State Medical Marijuana CME program covering clinical, legal, pharmacy, and physician perspectives on medical cannabis.<br /><br />Dr. Fred Goldstein opened by explaining housekeeping details for the CME, then presented an overview of cannabis pharmacology, safety, and his research on THC for chronic neuropathic pain. He emphasized that cannabis is widely used for chronic pain, may reduce opioid and non-opioid medication use, and has no known overdose deaths like opioids because it does not suppress respiration. He reviewed the endocannabinoid system, THC/CBD differences, adverse effects, and his pilot studies showing reductions in pain scores and analgesic use. He also highlighted a patient interview describing major improvements in pain, sleep, and quality of life.<br /><br />Dr. Rebecca McCaskey described the pharmacist’s role in Pennsylvania dispensaries: reviewing certifications, counseling patients, checking drug interactions, guiding product selection, and helping with dosing and follow-up. She explained product forms (tinctures, capsules, topicals, patches, inhaled products, suppositories, RSO), caregiver rules, and barriers such as cost, supply, and hospital restrictions.<br /><br />Dr. Gretchen Maurer discussed a physician’s perspective, stressing patient-centered care, cautious dosing, and use in chronic pain, spasticity, and select neurologic conditions. She reviewed evidence for CBD in epilepsy, the entourage effect, side effects, and several patient cases.<br /><br />Dr. Larry Finkelstein focused on Pennsylvania laws, certification requirements, qualifying conditions, and growing legislative oversight. He emphasized documentation, patient safety, driving impairment, and employer issues.<br /><br />Dr. Susan Peck covered cannabis use in pregnancy, warning about placental transfer, fetal exposure, possible neurodevelopmental risks, and the need for screening and abstinence counseling.<br /><br />Dr. Sarah Mullins closed with real-world case studies showing cannabis as a harm-reduction tool in pain, epilepsy, migraines, cancer, and palliative care, while stressing careful patient selection and shared decision-making.
Asset Caption
On-demand live recording of our PA-State Approved Medical Marijuana 4-hour training course
Keywords
medical marijuana
Pennsylvania
cannabis pharmacology
chronic pain
neuropathic pain
endocannabinoid system
THC
CBD
pharmacist counseling
dispensary
physician certification
qualifying conditions
pregnancy risks
harm reduction
patient case studies
×
Please select your language
1
English